(Q36609857)

15 August 2017

1 reference

title

Management of hyperphosphatemia (English)

1 reference

15 August 2017

Martin K Kuhlmann

1

1 reference

15 August 2017

publication date

1 October 2006

1 reference

Hemodialysis International

15 August 2017

published in

1 reference

15 August 2017

volume

10

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

338-345

1 reference

Clinical subtypes of Alzheimer's disease

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Phosphate kinetics during hemodialysis: Evidence for biphasic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Effective diffusion volume flow rates (Qe) for urea, creatinine, and inorganic phosphorous (Qeu, Qecr, QeiP) during hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Time and exercise improve phosphate removal in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Calcium and phosphate balance with quotidian hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Bile acid binding to sevelamer HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

Phosphate binders: new products and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00126.X

10.1111/J.1542-4758.2006.00126.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference